| |
| |
|
| Insider
Information: |
Mulligan Seamus |
| Relationship: |
Director |
| City: |
Dublin 2 |
| State: |
L2 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,220,947 |
|
|
Indirect Shares
|
1,410,544 |
|
|
| Direct
Value |
$128,336,619 |
|
|
|
Indirect Value
|
$97,110,532 |
|
|
| Total
Shares |
2,631,491 |
|
|
| Total
Value |
$225,447,151 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2023-08-11 |
1,172,375 |
2012-03-09 |
864,954 |
Premium* |
|
|
Emergent Biosolutions Inc. |
EBS |
Director |
2019-03-19 |
48,572 |
2019-03-19 |
545,590 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
42 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2015-11-20 |
4 |
AS |
$144.12 |
$2,564,368 |
D/D |
(17,725) |
1,140,790 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2016-02-23 |
4 |
AS |
$120.68 |
$3,431,904 |
D/D |
(27,968) |
1,102,579 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2016-05-24 |
4 |
AS |
$148.65 |
$4,203,339 |
D/D |
(27,968) |
1,074,611 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2016-08-25 |
4 |
AS |
$126.65 |
$3,588,787 |
D/D |
(27,968) |
1,048,008 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2014-12-23 |
4 |
AS |
$160.59 |
$5,397,896 |
D/D |
(33,275) |
1,273,930 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2020-05-27 |
4 |
B |
$109.55 |
$3,894,058 |
D/D |
35,000 |
1,152,788 |
2.39 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2014-09-24 |
4 |
AS |
$160.75 |
$5,777,692 |
D/D |
(35,294) |
1,321,911 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2014-06-24 |
4 |
AS |
$147.08 |
$7,477,749 |
D/D |
(49,953) |
1,405,602 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2014-09-11 |
4 |
AS |
$175.00 |
$8,750,000 |
D/D |
(50,000) |
1,357,205 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2015-03-18 |
4 |
AS |
$185.00 |
$9,250,000 |
D/D |
(50,000) |
1,207,205 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2015-03-25 |
4 |
AS |
$172.13 |
$8,729,522 |
D/D |
(50,000) |
1,157,205 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2018-11-15 |
4 |
B |
$141.86 |
$7,228,001 |
D/D |
50,000 |
1,100,868 |
2.39 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2013-03-08 |
4 |
S |
$58.28 |
$24,769,000 |
D/D |
(425,000) |
2,003,305 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2014-03-04 |
4 |
S |
$156.25 |
$85,937,500 |
D/D |
(550,000) |
1,455,555 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2012-03-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
864,954 |
2,426,055 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2012-03-09 |
4 |
GA |
$0.00 |
$0 |
I/I |
864,954 |
864,954 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2012-03-09 |
4 |
S |
$49.56 |
$99,120,000 |
D/D |
(2,000,000) |
3,291,009 |
0 |
- |
|
42 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
